Structured evidence table for Pea Protein Appetite Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Pea Protein Appetite Randomized Trial | In particular, whey protein has demonstrated strong potential for postprandial glucose management, and more recent findings highlighted evidence for increased efficacy of whey protein when consumed before, rather than with a carbohydrate-rich meal. | 2 | Elbira A (2026) | Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study. |
| Pea Protein Appetite Randomized Trial | Given the strong interest yet limited evidence on plant-based protein, the present study compared the potential of pea protein consumed prior to carbohydrates, on postprandial glucose as well as satiety and blood pressure (BP). | 2 | Elbira A (2026) | Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study. |
| Pea Protein Appetite Randomized Trial | Results Both PP and PrePP significantly reduced postprandial glucose excursion (0.46 vs. | 2 | Elbira A (2026) | Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study. |
| Pea Protein Appetite Randomized Trial | Purpose Protein intake has shown benefits to mitigate postprandial hyperglycaemic excursions. | 2 | Elbira A (2026) | Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study. |
| Pea Protein Appetite Randomized Trial | Mimio improved more over time in all hunger and satiety metrics than placebo (Hunger and Satiety Composite Score Mann-Kendall p = 2.2*10− 16). | 4 | Grant AD (2026) | A novel fasting mimetic (Mimio) creates fasting-like benefits to hunger control, oxidative stress, and cardiometabolic health in humans. |
| Pea Protein Appetite Randomized Trial | More participants in the Mimio group improved daily ratings of hunger and appetite compared to placebo, including 91% vs. | 4 | Grant AD (2026) | A novel fasting mimetic (Mimio) creates fasting-like benefits to hunger control, oxidative stress, and cardiometabolic health in humans. |
| Pea Protein Appetite Randomized Trial | Mimio significantly reduced total cholesterol, LDL cholesterol, LDL particle number, oxidized LDL, non-HDL cholesterol and fasting glucose compared to placebo (Student’s t-test p < 0.05). | 4 | Grant AD (2026) | A novel fasting mimetic (Mimio) creates fasting-like benefits to hunger control, oxidative stress, and cardiometabolic health in humans. |
| Pea Protein Appetite Randomized Trial | This decentralized, double-blind, randomized, placebo-controlled trial investigated the impact of a novel fasting mimetic “Mimio” on hunger, satiety, digestive symptoms, metabolism, cognition and wellbeing in overweight older adults with elevated HbA1c. | 4 | Grant AD (2026) | A novel fasting mimetic (Mimio) creates fasting-like benefits to hunger control, oxidative stress, and cardiometabolic health in humans. |
Source documents